Is highly-sensitive troponin testing advancing clinical practice, improving outcomes and cost-effective in the investigation and management of chest pain in the Emergency Department?

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Expensive next generation blood tests offer the promise of more efficient detection of heart muscle damage in people with chest pain presenting to the Emergency Department. We aim to evaluate the treatment, management, cost and outcome at 1 year before and after these new blood tests were introduced in a national multi-hospital study.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2021

Funding Scheme: Project Grants

Funding Amount: $1,193,966.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Emergency Medicine

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cost-effectiveness | emergency medicine | health outcomes | health service utilisation | myocardial ischaemia